Certara, the leading global technology-enabled drug development and drug
safety consultancy, announced the appointment of new chief executive
officer Dr. Edmundo Muniz.
Dr. Muniz joins Certara from Kirax Corporation, where he had served as president and chief executive officer, since 2005. In that role, he focussed on acquiring, developing and commercialising innovative specialty care therapies for oncology, pain, inflammation, acute and supportive care. Prior to that position, Dr. Muniz held several senior executive roles at Eli Lilly and Company, including Head of Worldwide Pharmacovigilance and Epidemiology, Cardiovascular Business Unit Leader, and vice president of Oncology Clinical Development.
Dr. Muniz joins Certara from Kirax Corporation, where he had served as president and chief executive officer, since 2005. In that role, he focussed on acquiring, developing and commercialising innovative specialty care therapies for oncology, pain, inflammation, acute and supportive care. Prior to that position, Dr. Muniz held several senior executive roles at Eli Lilly and Company, including Head of Worldwide Pharmacovigilance and Epidemiology, Cardiovascular Business Unit Leader, and vice president of Oncology Clinical Development.
No comments:
Post a Comment